Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes

Pediatric Diabetes

Volumn 15, Issue 8, 2014, Pages 543-549

  Redondo, Mj ^a   Rodriguez, Lm ^a   Haymond, Mw ^a   Hampe, Cs ^b   Smith, Eo ^a   Balasubramanyam, A ^a   Devaraj, S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adipokine; Adiponectin; Chemerin; Children; Cytokines; IFN gamma; IL 10; IL 12; IL 6; IL 8; Leptin; Obesity; Omentin; Resistin; TNF alpha; Type 1 diabetes; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMERIN; CYTOKINE; GAMMA INTERFERON; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE TYPE 1 DIABETES; CAUCASIAN; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEAN BODY WEIGHT; MALE; MOLECULAR WEIGHT; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; BLOOD; BODY WEIGHT; CHILDHOOD OBESITY; COMPLICATION; DIABETES MELLITUS, TYPE 1; FOLLOW UP; ONSET AGE; PRESCHOOL CHILD;

ADIPOKINES; ADIPOSITY; ADOLESCENT; AGE OF ONSET; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PEDIATRIC OBESITY; THINNESS;

EID: 84920279467     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12159     Document Type: Article

References (39)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012: 307: 483-490 [Epub 19 January 2012].
2. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, Group ES. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009: 373: 2027-2033 [Epub 2 June 2009].
3. Liu LL, Lawrence JM, Davis C et al. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 2010: 11: 4-11 [Epub 29 May 2009].
4. Kaminski BM, Klingensmith GJ, Beck RW et al. Body Mass Index at the Time of Diagnosis of Autoimmune Type 1 Diabetes in Children. J Pediatr 2012: 162: 736-740 [Epub 25 October 2012].
5. Redondo MJ, Rodriguez LM, Escalante M, O'Brian Smith E, Balasubramanyam A, Haymond MW. Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes 2012: 13: 564-571 [Epub 31 May 2012].
6. Purnell JQ, Zinman B, Brunzell JD, Group DER. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC). Circulation 2013: 127: 180-187 [Epub 6 December 2012].
7. Marcovecchio ML, Chiarelli F. Microvascular disease in children and adolescents with type 1 diabetes and obesity. Pediatr Nephrol 2011: 26: 365-375 [Epub 20 August 2010].
8. Shah AS, Dolan LM, Lauer A et al. Adiponectin and arterial stiffness in youth with type 1 diabetes: the SEARCH for diabetes in youth study. J Pediatr Endocrinol Metab 2012: 25 (7-8): 717-721 [Epub 20 November 2012].
9. Maahs DM, Jalal D, Chonchol M, Johnson RJ, Rewers M, Snell-Bergeon JK. Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care 2013: 36: 2607-2614 [Epub 10 July 2013].
10. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006: 444: 860-867 [Epub 15 December 2006].
11. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011: 11: 85-97 [Epub 22 January 2011].
12. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005: 111: 1448-1454 [Epub 23 March 2005].
13. Ouchi N, Kihara S, Funahashi T et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003: 107: 671-674 [Epub 13 February 2003].
14. Ahima RS, Prabakaran D, Mantzoros C et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996: 382: 250-252 [Epub 18 July 1996].
15. Tan BK, Adya R, Farhatullah S et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008: 57: 801-808 [Epub 5 January 2008].
16. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001: 409: 307-312 [Epub 24 February 2001].
17. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance--the emerging role of the adipocyte as an endocrine organ. N Engl J Med 2001: 345: 1345-1346 [Epub 17 January 2002].
18. Bozaoglu K, Bolton K, McMillan J et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007: 148: 4687-4694 [Epub 21 July 2007].
19. Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005: 307: 426-430 [Epub 18 December 2004].
20. Verrijn Stuart AA, Schipper HS, Tasdelen I et al. Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. J Clin Endocrinol Metab 2012: 97: 463-472 [Epub 25 November 2011].
21. Snell-Bergeon JK, West NA, Mayer-Davis EJ et al. Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study. J Clin Endocrinol Metab 2010: 95: 2868-2876 [Epub 8 April 2010].
22. Soliman AT, Omar M, Assem HM et al. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Metabolism 2002: 51: 292-296 [Epub 12 March 2002].
23. Huml M, Kobr J, Siala K et al. Gut peptide hormones and pediatric type 1 diabetes mellitus. Physiol Res 2011: 60: 647-658 [Epub 18 May 2011].
24. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000: 314: 1-27 [Epub 24 February 2001].
25. Oak S, Gilliam LK, Landin-Olsson M et al. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci U S A 2008: 105: 5471-5476 [Epub 28 March 2008].
26. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003: 52: 1128-1136 [Epub 30 April 2003].
27. Hanaki K, Becker DJ, Arslanian SA. Leptin before and after insulin therapy in children with new-onset type 1 diabetes. J Clin Endocrinol Metab 1999: 84: 1524-1526 [Epub 14 May 1999].
28. van Vliet M, Van der Heyden JC, Diamant M et al. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 2010: 156: 923-929 [Epub 13 March 2010].
29. Azrad M, Gower BA, Hunter GR, Nagy TR. Racial differences in adiponectin and leptin in healthy premenopausal women. Endocrine 2013: 43: 586-592 [Epub 18 September 2012].
30. Khan UI, Wang D, Sowers MR et al. Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). Metabolism 2012: 61: 1261-1269 [Epub 27 March 2012].
31. Rasmussen-Torvik LJ, Wassel CL, Ding J et al. Associations of body mass index and insulin resistance with leptin, adiponectin, and the leptin-to-adiponectin ratio across ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Ann Epidemiol 2012: 22: 705-709 [Epub 30 August 2012].
32. Twombly JG, Long Q, Zhu M et al. Diabetes care in black and white veterans in the southeastern U.S. Diabetes Care 2010: 33: 958-963 [Epub 28 January 2010].
33. Petitti DB, Klingensmith GJ, Bell RA et al. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr 2009: 155: 668-672 e1-3 [Epub 1 August 2009].
34. Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab 2013: 98: E514-E517 [Epub 11 January 2013].
35. Tan BK, Pua S, Syed F, Lewandowski KC, O'Hare JP, Randeva HS. Decreased plasma omentin-1 levels in type 1 diabetes mellitus. Diabet Med 2008: 25: 1254-1255 [Epub 3 December 2008].
36. Weigert J, Neumeier M, Wanninger J et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010: 72: 342-348 [Epub 30 June 2009].
37. Bluher M, Rudich A, Kloting N et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012: 35: 342-349 [Epub 23 December 2011].
38. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993: 259: 87-91 [Epub 1 January 1993].
39. Sharma AM, Staels B. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007: 92: 386-395 [Epub 7 December 2006].